108 related articles for article (PubMed ID: 33179081)
1. Laminin‑332 mediates proliferation, apoptosis, invasion, migration and epithelial‑to‑mesenchymal transition in pancreatic ductal adenocarcinoma.
Huang C; Chen J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179081
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/mTOR cascade.
Kirtonia A; Pandey AK; Ramachandran B; Mishra DP; Dawson DW; Sethi G; Ganesan TS; Koeffler HP; Garg M
Cell Mol Life Sci; 2022 Jun; 79(7):362. PubMed ID: 35699794
[TBL] [Abstract][Full Text] [Related]
3. The Vacuolar H
Flinck M; Hagelund S; Gorbatenko A; Severin M; Pedraz-Cuesta E; Novak I; Stock C; Pedersen SF
Cells; 2020 Feb; 9(2):. PubMed ID: 32085585
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic ductal adenocarcinoma cells employ integrin α6β4 to form hemidesmosomes and regulate cell proliferation.
Humphries JD; Zha J; Burns J; Askari JA; Below CR; Chastney MR; Jones MC; Mironov A; Knight D; O'Reilly DA; Dunne MJ; Garrod DR; Jorgensen C; Humphries MJ
Matrix Biol; 2022 Jun; 110():16-39. PubMed ID: 35405272
[TBL] [Abstract][Full Text] [Related]
5. Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells.
Islam K; Balasubramanian B; Venkatraman S; Thummarati P; Tunganuntarat J; Phueakphud N; Kanjanasirirat P; Khumpanied T; Kongpracha P; Kittirat Y; Tohtong R; Janvilisri T; Wongtrakoongate P; Borwornpinyo S; Namwat N; Suthiphongchai T
Sci Rep; 2023 Dec; 13(1):22598. PubMed ID: 38114514
[TBL] [Abstract][Full Text] [Related]
6. Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model.
Chen YC; Lan YW; Huang SM; Yen CC; Chen W; Wu WJ; Staniczek T; Chong KY; Chen CM
Stem Cell Res Ther; 2022 Jun; 13(1):235. PubMed ID: 35659367
[TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis.
Xu D; Liu A; Liu Q; Zhang H; Tian M; Bian Y; Zhang X; Ying M; Shen H
Biochem Pharmacol; 2023 Nov; 217():115810. PubMed ID: 37717690
[TBL] [Abstract][Full Text] [Related]
8. Polymerized laminin-332 matrix supports rapid and tight adhesion of keratinocytes, suppressing cell migration.
Kariya Y; Sato H; Katou N; Kariya Y; Miyazaki K
PLoS One; 2012; 7(5):e35546. PubMed ID: 22563463
[TBL] [Abstract][Full Text] [Related]
9. Expression of laminin332 γ2 at the invasive front is associated with tumor budding and poor prognosis in cutaneous squamous cell carcinoma.
Katayama S; Koga K; Fujimoto M; Matsuzaki I; Nabeshima K; Imafuku S; Hamasaki M
J Dermatol; 2023 Dec; 50(12):1585-1593. PubMed ID: 37752805
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive detection of invasive lung cancer cells by novel antibody against amino-terminal domain of laminin γ2 chain.
Miyazaki K; Oyanagi J; Sugino A; Sato H; Yokose T; Nakayama H; Miyagi Y
Cancer Sci; 2016 Dec; 107(12):1909-1918. PubMed ID: 27685891
[TBL] [Abstract][Full Text] [Related]
11. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma.
Kim IK; Diamond MS; Yuan S; Kemp SB; Kahn BM; Li Q; Lin JH; Li J; Norgard RJ; Thomas SK; Merolle M; Katsuda T; Tobias JW; Baslan T; Politi K; Vonderheide RH; Stanger BZ
Nat Commun; 2024 Feb; 15(1):1532. PubMed ID: 38378697
[TBL] [Abstract][Full Text] [Related]
12. Laminin N-terminus α31 is upregulated in invasive ductal breast cancer and changes the mode of tumour invasion.
Troughton LD; O'Loughlin DA; Zech T; Hamill KJ
PLoS One; 2022; 17(3):e0264430. PubMed ID: 35231053
[TBL] [Abstract][Full Text] [Related]
13. Expression of laminin-5 enhances tumorigenicity of human fibrosarcoma cells in nude mice.
Mizushima H; Hirosaki T; Miyata S; Takamura H; Miyagi Y; Miyazaki K
Jpn J Cancer Res; 2002 Jun; 93(6):652-9. PubMed ID: 12079513
[TBL] [Abstract][Full Text] [Related]
14. SOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma.
Han S; Zhang M; Qu X; Wu Z; Huang Z; Hu Y; Li Y; Cui L; Si L; Liu J; Shao Y
Oncogene; 2024 Feb; 43(6):434-446. PubMed ID: 38102338
[TBL] [Abstract][Full Text] [Related]
15. Integrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues.
Atay S
PeerJ; 2020; 8():e10141. PubMed ID: 33194391
[TBL] [Abstract][Full Text] [Related]
16. Effects of miR‑93 on epithelial‑to‑mesenchymal transition and vasculogenic mimicry in triple‑negative breast cancer cells.
An G; Lu F; Huang S; Bai J; He L; Liu Y; Hou L
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179106
[TBL] [Abstract][Full Text] [Related]
17. LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma.
Okada Y; Takahashi N; Takayama T; Goel A
Carcinogenesis; 2021 Apr; 42(4):546-556. PubMed ID: 33624791
[TBL] [Abstract][Full Text] [Related]
18. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis.
Islam S; Kitagawa T; Baron B; Abiko Y; Chiba I; Kuramitsu Y
Sci Rep; 2021 May; 11(1):10563. PubMed ID: 34007003
[TBL] [Abstract][Full Text] [Related]
19. Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma.
Okada Y; Nishiwada S; Yamamura K; Sho M; Baba H; Takayama T; Goel A
Eur J Cancer; 2021 Mar; 146():125-134. PubMed ID: 33607476
[TBL] [Abstract][Full Text] [Related]
20. High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.
Tian C; Li X; Ge C
Mol Med; 2021 Jun; 27(1):62. PubMed ID: 34134622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
